Basic oral care for hematology–oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT)

TY - JOUR

T1 - Basic oral care for hematology–oncology patients and hematopoietic stem cell transplantation recipients

T2 - a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT)

AU - Elad, Sharon

AU - Raber-Durlacher, Judith E

AU - Brennan, Michael T

AU - Saunders, Deborah P

AU - Mank, Arno P

AU - Zadik, Yehuda

AU - Quinn, Barry

AU - Epstein, Joel B

AU - Blijlevens, Nicole M A

AU - Waltimo, Tuomas

AU - Passweg, Jakob R

AU - Correa, M Elvira P

AU - Dahllöf, Göran

AU - Garming-Legert, Karin U E

AU - Logan, Richard M

AU - Potting, Carin M J

AU - Shapira, Michael Y

AU - Soga, Yoshihiko

AU - Stringer, Jacqui

AU - Stokman, Monique A

AU - Vokurka, Samuel

AU - Wallhult, Elisabeth

AU - Yarom, Noam

AU - Jensen, Siri Beier

PY - 2015/1

Y1 - 2015/1

N2 - PURPOSE: Hematology-oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic oral care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the oral complications, expert opinion is needed to shape the current optimal protocols.METHODS: This position paper was developed by members of the Oral Care Study Group, Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT) in attempt to provide guidance to the health care providers managing these patient populations.RESULTS: The protocol on basic oral care outlined in this position paper is presented based on the following principles: prevention of infections, pain control, maintaining oral function, the interplay with managing oral complications of cancer treatment and improving quality of life.CONCLUSION: Using these fundamental elements, we developed a protocol to assist the health care provider and present a practical approach for basic oral care. Research is warranted to provide robust scientific evidence and to enhance this clinical protocol.

AB - PURPOSE: Hematology-oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic oral care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the oral complications, expert opinion is needed to shape the current optimal protocols.METHODS: This position paper was developed by members of the Oral Care Study Group, Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT) in attempt to provide guidance to the health care providers managing these patient populations.RESULTS: The protocol on basic oral care outlined in this position paper is presented based on the following principles: prevention of infections, pain control, maintaining oral function, the interplay with managing oral complications of cancer treatment and improving quality of life.CONCLUSION: Using these fundamental elements, we developed a protocol to assist the health care provider and present a practical approach for basic oral care. Research is warranted to provide robust scientific evidence and to enhance this clinical protocol.

U2 - 10.1007/s00520-014-2378-x

DO - 10.1007/s00520-014-2378-x

M3 - Journal article

C2 - 25189149

SN - 0941-4355

VL - 23

SP - 223

EP - 236

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

IS - 1

ER -